Snapshot from Apr 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Nicotinamide riboside
Commodity

Nicotinamide riboside

Tracked across 1 events · 8 articles · First seen Apr 01, 2026 · Last active Apr 06, 2026

Sentiment
-30
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 -30
Tech
NAD+ Supplements Hinder Pancreatic Cancer Chemotherapy
Nicotinamide riboside (NR) was also found to help cancer cells resist chemotherapy, though to a lesser extent than Nicotinamide mononucleotide. This could negatively impact its sales to cancer patients.
Apr 01, 2026 · 8 articles
NEWSDESK
Track Nicotinamide riboside live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.